• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ACS Nanosci Au . Development of an Immunoassay for Highly Pathogenic Avian Influenza (H5N1) across Diverse Sample Matrices

tetano

Editor, Senior Moderator
ACS Nanosci Au


. 2025 Feb 13;5(2):93-99.
doi: 10.1021/acsnanoscienceau.4c00072. eCollection 2025 Apr 16. Development of an Immunoassay for Highly Pathogenic Avian Influenza (H5N1) across Diverse Sample Matrices

Josselyn Mata Calidonio[SUP] 1 [/SUP], Arianna I Maddox[SUP] 2 [/SUP], Dhruvi S Patel[SUP] 2 [/SUP], Jonathan B Dain[SUP] 2 [/SUP], Melba Torres Sosa[SUP] 2 [/SUP], Nichola J Hill[SUP] 2 [/SUP], Kimberly Hamad-Schifferli[SUP] 1 3 [/SUP]



Affiliations
Abstract

Avian influenza of the highly pathogenic subtype H5N1 has emerged as a global health concern, becoming endemic in wild birds and increasingly transmitting to poultry, livestock, and humans. This study aimed to develop a robust immunoassay for the rapid detection of the H5N1 highly pathogenic avian influenza virus across various sample matrices, including sera, milk, eggs, and bird samples. The assay targets the hemagglutinin (HA) protein, chosen for its abundance and accessibility on the virus surface. Utilizing gold nanospheres conjugated with α-HA IgG antibodies, the assay generated distinct colorimetric signals for both negative and positive samples. The test initially demonstrated an effective colorimetric response with a limit of detection (LOD) of 0.16 nM in human serum and was further optimized for running in whole milk, exhibiting an LOD of 1.72 nM. The assay exhibited versatility across different serum types and dairy products, although high-viscosity samples like heavy cream presented challenges. Furthermore, the immunoassay successfully detected HA of H5N1 in complex sample matrices such as oral, cloacal, and fecal samples from birds. This rapid and sensitive immunoassay represents a significant advance in HPAI surveillance tools, improving prospects for real-time detection to control outbreaks.


 
Back
Top Bottom